Electromagnetic method and apparatus to measure constituents of human or animal tissue

• US 5,178,142 A
• Filed: 07/03/1991
• Issued: 01/12/1993
• Est. Priority Date: 05/23/1989
• Status: Expired due to Term

• Current Assignee: Lock J. Paul, Morrow & Co. Partnership, Robert A. Peura, Stephen Wells
• Original Assignee: VivaScan Corp.
• Inventors: Wang, Yi, Harjunmaa, Hannu, Mendelson, Yitzhak
• Primary Examiner(s): Cohen, Lee S.
• Assistant Examiner(s): Pontius, Kevin
• Application Number:
  US07/725,441
• Time in Patent Office: 559 Days
• Field of Search: 128/633-634, 128/664, 356/39, 356/41, 250/339, 250/341, 250/351
• US Class Current: 600/310
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence
• CPC Class Codes: G01N 21/359 using near infrared light

Abstract

To determine glucose or other constituents of the human or animal body, a stabilized near-infrared radiation beam containing two alternating wavelengths that have approximately equal extinction coefficients in the tissue, is directed onto the sample area, the transmitted signal alternating component is zeroed by tuning one of the wavelengths, the extracellular-to-intracellular fluid ratio of the tissue is changed by exerting varying mechanical pressure on the tissue, or the ratio is allowed to change as a result of the natural pulsation. The alternating component of the transmitted beam power is measured in the changed fluid ratio state. The amplitude of the alternating-current (AC) signal given by the detector, is taken to represent glucose concentration or the difference from a preset reference concentration.

Claims

1. Non-invasive method for measuring the concentration of predetermined analytes in living body tissue, comprising the steps of:

a) generating a combined beam of electromagnetic radiation comprised of alternate and repetitive periods of radiation having different wavelengths, the two wavelengths having different absorption coefficients for the analyte being sought, at least one of the wavelengths being tunable, and the repetitive periods forming a measurement cycle;

b) detecting the combined beam with a primary detector for generating a primary electrical signal proportional to the intensity of the combined beam;

c) detecting the combined beam with a reference detector for generating a reference signal proportional to the intensity of the combined beam and wherein the electrical response generated by the two period radiations in both detectors is substantially equal in magnitude, thus producing a substantially zero alternating component in the signals of both detectors,

d) directing the combined beam on the subject tissue so that radiation transmitted or reflected by the tissue reaches the primary detector;

e) controlling the intensity relation between the periods using the reference signal and tuning the wavelength of one of the periods to obtain a substantially zero alternating component in the primary signal;

f) changing the ratio of extracellular fluid content to intracellular fluid content in the tissue; and

g) using the change in the primary signal produced by the principal detector as a result of the fluid ratio change to measure the concentration of the analyte in the tissue.

2. The method according to claim 1, where the combined beam passes through the tissue before being detected by the primary detector.

3. The method according to claim 2, wherein the fluid ratio change comprises change in tissue thickness.

4. The method according to claim 3, wherein the tissue thickness change is substantially equal to the inverse of the extinction coefficient of the tissue at the wavelengths used.

5. The method according to claim 3, wherein the tissue thickness change is repeated cyclically, and the primary signal variation over the cycle is used as a measure of the concentration of the analyte in blood.

6. The method according to claim 1, wherein changing the fluid ratio is achieved by applying pressure on the surface of the tissue.

7. The method according to claim 1, wherein the fluid ratio change is caused by the natural pulsation due to the heartbeat, and the measurement cycle is synchronized to such pulsation.

8. The method according to claim 1 wherein the analyte is a homologous body material, and the wavelengths are within the range of 1 to 2.5 micrometers.

9. The method according to claim 1 for measuring glucose concentration in human or animal body tissue and having one of the wavelengths selected from the interval 2125-2185 nm and another one from the interval 2240-2300 nm.

10. The method of claim 1 wherein the analyte is glucose and one of the wavelengths is selected from the interval 1500-1650 nm and another one is from the interval 1650-1800 nm.

11. The method of claim 1, where the measurement is repeated using one or more additional wavelength pairs and the desired result is obtained from the signal values at each wavelength pair using a mathematical transformation.

12. The method of claim 1, where, before the combined beam is directed on the tissue, the primary and reference detector are equalized by controlling the intensity relation of the different wavelength periods so as to continually produce a minimum alternating signal from the primary detector, tuning the tunable wavelength over the tuning range and at the same time recording into a memory, as a function of the wavelength, a control signal required to produce said minimum alternating signal condition.

13. The method of claim 1 in which calibration is performed while the tissue is in the radiation beam, by blanking one of a pair of wavelength periods and measuring the resulting transmitted alternating single-wavelength signal amplitude and using the measured amplitude to normalize the change in the primary signal.

14. Apparatus for non-invasive measurement of the in vivo concentration of a predetermined analyte in bodily tissue comprising:

a) radiation means to generate an electromagnetic radiation probe beam containing two alternating wavelength portions where at least one of the wavelengths is tunable and the intensity of the radiation during at least one wavelength portion is controllable,

b) optical means to transmit the beam to the tissue;

c) reference detector means to detect a representative portion of the beam, prior to interaction with the tissue, and for generating a reference signal proportional to probe beam intensity;

d) primary detector means to detect at least a portion of the beam radiation after interaction with the tissue and for generating a primary signal proportional to interacted probe beam intensity;

e) electrical means to produce an off-set signal in response to the primary signal;

f) electrical means to produce a control signal from the reference signal and the off-set signal;

g) control means to control the intensity relation of the alternating portions of the probe beams, according to said control signal,

h) computing means to convert the primary signal to the concentration value of the analyte sought.

15. Apparatus according to claim 14, wherein the optical means includes means to collect the beam after interaction with the tissue to form an image on the primary detector of the area where the probe beam exits the tissue.

16. Apparatus according to claim 15, wherein the optical means comprises an optical fiber.

17. Apparatus according to claim 16 wherein the optical fiber is bifurcated at a proximal end with a first plurality of fibers for coupling the beam to the reference detector means and a second plurality of fibers for coupling the beam to the tissue for interaction and is bifurcated at a distal end with a third plurality of fibers for coupling the interacted beam to the primary detector means.

18. Non-invasive apparatus for measuring the concentration of predetermined analytes in living body tissue, comprising:

a) transmission means for generating a combined beam of electromagnetic radiation comprised of alternate and repetitive periods of radiation having different wavelengths, the two wavelengths having different absorption coefficients for the analyte being sought, at least one of the wavelengths being tunable;

b) a primary detector means for detecting the combined beam before and after interacting with the tissue and for generating a primary electrical signal proportional to the intensity of the combined beam before and after said interaction;

c) a reference detector means for detecting the combined beam for generating a reference signal proportional to the intensity of the combined beam and wherein the electrical response generated by the two period radiations in both detectors is substantially equal in magnitude, thus producing a substantially zero alternating component in the signals of both detectors,

d) coupling means for directing the combined beam onto the subject tissue so that radiation transmitted or reflected by the tissue is coupled to the primary detector means;

e) control means for controlling the intensity relation between the radiation periods in response to the reference signal to tune the wavelength of one of the periods to obtain a substantially zero alternating component in the primary signal;

f) change means for changing the ratio of extracellular fluid content to intracellular fluid content in the tissue; and

g) display means responsive to the change, in the primary signal produced by the primary detector means as a result of the fluid ratio change to measure the concentration of the analyte in the tissue.

19. Apparatus according to claim 18, wherein the means for directing directs the combined beam through the tissue before being detected by the primary detector means.

20. Apparatus according to claim 18, wherein the change means comprises means for changing the thickness of the tissue.